The serum levels of interleukin 17 in patients with neuromyelitis optica spectrum disorder

被引：0
|
作者：
Varzandi, T. [1 ]
Omidifar, A. [2 ]
Torkamani, M. [3 ]
Rezaeimanesh, N. [1 ]
Kazemi, R. [1 ]
Sahraian, M. A. [1 ]
Moghadasi, A. N. [1 ]
Maghbooli, Z. [1 ]
机构：
[1] Univ Tehran Med Sci, Neurosci Inst, Multiple Sclerosis Res Ctr, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Fac Paramed Sci, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Food Ind Dept, Tehran, Iran
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0173
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [41] Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder
    Kim, S. -H.
    Kwak, K.
    Hyun, J. -W.
    Jeong, I. H.
    Jo, H. -J.
    Joung, A.
    Kim, J. -H.
    Lee, S. H.
    Yun, S.
    Joo, J.
    Lee, J. -M.
    Kim, H. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (07) : 1165 - 1173
  • [42] Intractable cough as characteristic symptom of neuromyelitis optica and neuromyelitis optica spectrum disorder
    Fujita-Nakata, M.
    Tomioka, R.
    Tanaka, K.
    Nakanishi, M.
    Nagayama, S.
    Takahashi, R.
    Machiya, T.
    Hamada, T.
    Matsui, M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (04) : 576 - 577
  • [43] MULTIDIMENSIONAL EVALUATION OF INEBILIZUMAB IN PATIENTS WITH NEUROMYELITIS OPTICA SPECTRUM DISORDER
    Fortunato, A.
    Antonini, D.
    Basile, M.
    Di Brino, E.
    Di Pippo, S.
    Falasca, G.
    Rumi, F.
    Cicchetti, A.
    VALUE IN HEALTH, 2023, 26 (12) : S348 - S348
  • [44] Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder
    Singh, Pratap
    Gao, Xiang
    Kleijn, Huub Jan
    Bellanti, Francesco
    Pelto, Ryan
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [45] Radiological characteristics of Neuromyelitis Optica Spectrum Disorder patients in Egypt
    Nasreldein, A.
    Farweez, H.
    Elfetoh, N. Abo
    Mahmoud, D.
    Badawy, E.
    Hassanein, S.
    Khedr, E.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 149 - 149
  • [46] Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder
    Mealy, Maureen A.
    Cook, Lawrence J.
    Pache, Florence
    Velez, Diego L.
    Borisow, Nadja
    Becker, Daniel
    Arango, Jorge A. Jimenez
    Paul, Friedemann
    Levy, Michael
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 23 : 78 - 82
  • [47] Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder
    Wang, Yuge
    Zhou, Yifan
    Sun, Xiaobo
    Lu, Tingting
    Wei, Lei
    Fang, Ling
    Chen, Chen
    Huang, Qiao
    Hu, Xueqiang
    Lu, Zhengqi
    Peng, Lisheng
    Qiu, Wei
    NEUROIMMUNOMODULATION, 2016, 23 (5-6) : 352 - 358
  • [48] Immunosuppressive therapy in elderly patients with neuromyelitis optica spectrum disorder
    Kim, Su-Hyun
    Kim, Ki Hoon
    Chung, Yeon Hak
    Min, Ju-Hong
    Han, Hee Jo
    Kim, Seung Woo
    Shin, Ha Young
    Lee, Eun-Jae
    Lim, Young-Min
    Kwon, Young Nam
    Kim, Sung Min
    Hyun, Jae-Won
    Kim, Ho Jin
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 146 - 146
  • [49] Seizure incidence among neuromyelitis optica spectrum disorder patients
    Etemadifar, M.
    Sabeti, F.
    Khorvash, R.
    Mirbagheri, M.
    Nouri, H.
    Salari, M.
    REVUE NEUROLOGIQUE, 2021, 177 (06) : 655 - 659
  • [50] The Effects of Race and Ethnicity on Patients with Neuromyelitis Optica Spectrum Disorder
    Cortez, Elyse
    Medina, Kelsey M.
    Edwards, James
    Kim, Bohan
    Sriwastava, Shitiz K.
    Samant, Rohan
    Lincoln, John A.
    Lindsey, John W.
    Gupta, Rajesh K.
    ANNALS OF NEUROLOGY, 2024, 96 : S90 - S90
12345